GENELUX CORPORATION Increase (Decrease) in Prepaid Expense and Other Assets
GENELUX CORPORATION (GNLX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$57.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$67.00K, a 115.99% decline year-over-year.
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $10.00K, a 94.15% decline year-over-year.
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$79.00K.
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$577.00K, a 266.76% decline year-over-year.
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$66.00K.
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$359.00K.
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$483.00K, a 387.50% decline from fiscal 2022.
- GENELUX CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2022 was $168.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$57.00K 10-Q · filed 2026-08-13 | -$136.00K derived: sum of 3 quarters · filed 2026-08-13 | -$713.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-07 | -$69.00K derived: sum of 2 quarters · filed 2026-05-07 | -$646.00K derived: sum of 3 quarters · filed 2026-05-07 | -$227.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$656.00K derived: sum of 2 quarters · filed 2026-03-19 | -$237.00K derived: sum of 3 quarters · filed 2026-08-13 | -$66.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | -$577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$158.00K derived: sum of 2 quarters · filed 2026-08-13 | $13.00K 10-Q · filed 2025-11-05 | -$914.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $590.00K 10-Q · filed 2026-08-13 | -$337.00K derived: sum of 3 quarters · filed 2026-08-13 | $9.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $171.00K 10-Q · filed 2026-05-07 | -$756.00K derived: sum of 2 quarters · filed 2026-05-07 | -$410.00K derived: sum of 3 quarters · filed 2026-05-07 | -$753.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$927.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$581.00K derived: sum of 2 quarters · filed 2026-03-19 | -$924.00K derived: sum of 3 quarters · filed 2026-03-19 | -$359.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.00K derived: sum of 2 quarters · filed 2025-11-05 | $568.00K 10-Q · filed 2025-11-05 | $270.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$343.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $222.00K 10-Q · filed 2025-08-07 | -$76.00K derived: sum of 3 quarters · filed 2025-08-07 | -$309.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $565.00K 10-Q · filed 2025-05-06 | $267.00K derived: sum of 2 quarters · filed 2025-05-06 | $34.00K derived: sum of 3 quarters · filed 2025-05-06 | -$141.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$531.00K derived: sum of 2 quarters · filed 2025-03-28 | -$706.00K derived: sum of 3 quarters · filed 2025-03-28 | -$483.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$408.00K derived: sum of 2 quarters · filed 2024-11-14 | -$185.00K 10-Q · filed 2024-11-14 | -$181.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $48.00K 10-Q · filed 2024-08-14 | $52.00K derived: sum of 3 quarters · filed 2024-08-14 | -$298.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $223.00K 10-Q · filed 2024-05-09 | $227.00K derived: sum of 2 quarters · filed 2024-05-09 | -$123.00K derived: sum of 3 quarters · filed 2024-05-09 | $768.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$346.00K derived: sum of 2 quarters · filed 2024-03-29 | $545.00K derived: sum of 3 quarters · filed 2024-03-29 | $168.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | -$350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $541.00K derived: sum of 2 quarters · filed 2023-11-14 | $164.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $891.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $514.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$377.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |